APA (7th ed.) Citation

Wilbie, D., Eising, S., Amo-Addae, V., Walther, J., Bosman, E., Lei, Z., . . . Mastrobattista, E. (2025). Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out. PLoS ONE, 20(9), 1. https://doi.org/10.1371/journal.pone.0332617

Chicago Style (17th ed.) Citation

Wilbie, Danny, Selma Eising, Vicky Amo-Addae, Johanna Walther, Esmeralda Bosman, Zhiyong Lei, Olivier G. de Jong, Jan J. Molenaar, and Enrico Mastrobattista. "Anti-cancer Compound Screening Identifies Aurora Kinase A Inhibition as a Means to Favor CRISPR/Cas9 Gene Correction over Knock-out." PLoS ONE 20, no. 9 (2025): 1. https://doi.org/10.1371/journal.pone.0332617.

MLA (9th ed.) Citation

Wilbie, Danny, et al. "Anti-cancer Compound Screening Identifies Aurora Kinase A Inhibition as a Means to Favor CRISPR/Cas9 Gene Correction over Knock-out." PLoS ONE, vol. 20, no. 9, 2025, p. 1, https://doi.org/10.1371/journal.pone.0332617.